Source: International Congress 2014 – COPD markers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Price, K. Bichel, D. West, V. L. Ashton, R. Stewart (Aberdeen, Cambridge, United Kingdom). Prescribing patterns for UK patients commencing first maintenance therapy for COPD. Eur Respir J 2014; 44: Suppl. 58, 4722

Member's Comments

No comment yet.

Related content which might interest you: Characterising patterns of prescribing for UK COPD patients with comorbidities or history of pneumonia Source: International Congress 2014 – COPD exacerbations Year: 2014 Clinical, functional and laboratory assessment of treatment efficacy in COPD patients Source: International Congress 2014 – Predictors Year: 2014 Association between inhaled corticosteroid use in COPD and incidence or worsening of type2 diabetes Source: International Congress 2014 – Markers Year: 2014 Integrated care reduces hospital utilization among patients with severe COPD Source: International Congress 2014 – COPD exacerbations Year: 2014 Metabolic syndrome in patients with COPD Source: International Congress 2014 – Clinical presentations Year: 2014 Mortality predictors in stable COPD Source: International Congress 2014 – Predictors Year: 2014 Effects of pharmacist interventions to inhalation medication adherence and lung functions in COPD patients at one stop service clinic Source: International Congress 2014 – COPD exacerbations Year: 2014 The parameters that may affect inhalation therapy success in elderly COPD and asthma patients Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015 The role of COPD in development of osteoporosis Source: International Congress 2014 – Markers Year: 2014 COPD and depression: Prevalence and interaction Source: International Congress 2014 – Comorbidities Year: 2014 Mukoregulatory drugs in treating COPD Source: International Congress 2014 – Predictors Year: 2014 Effectiveness of a comprehensive management program of fragile COPD patients Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD Year: 2014 Real-world prescribing patterns among newly diagnosed COPD patients receiving ICS: An analysis of UK patient dataset Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Effectiveness of self-treatment of exacerbations in COPD patients: Two-year follow-up of the COPE-II study Source: International Congress 2014 – Best abstracts in rehabilitation and chronic care (sponsored by MOTEK Medical) Year: 2014 Roflumilast added to triple therapy in severe COPD patients with frequent exacerbations: Efficacy and tolerability Source: International Congress 2014 – Markers Year: 2014 Distribution and outcomes of the new Spanish phenotype-based guideline for COPD Source: International Congress 2014 – COPD exacerbations Year: 2014 Inter-relationship of different types of respiratory symptoms in COPD Source: International Congress 2014 – Comorbidities Year: 2014 Cardiovascular status of patients with a severe form of COPD Source: International Congress 2015 – Diagnosing and management of COPD in primary care Year: 2015 Hospital treatment costs of exacerbations in COPD patients with indications for LTOT Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Combination therapy versus separate therapy in real-life primary care asthma patients Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care Year: 2015